TG THERAPEUTICS, INC. Convertible Preferred Stock, Shares Issued upon Conversion
TG THERAPEUTICS, INC. (TGTX) had Convertible Preferred Stock, Shares Issued upon Conversion of 8.89 shares as of 2013-12-31, per its 10-K filed 2014-03-07.
Discontinued › Notes › Equity
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2014-03-07
- 2013-12-31: Convertible Preferred Stock, Shares Issued upon Conversion 8.89 shares.
- 2012-06-30: Convertible Preferred Stock, Shares Issued upon Conversion 1.15M shares.
- 2012-04-30: Convertible Preferred Stock, Shares Issued upon Conversion 9.86M shares.
- 2011-12-29: Convertible Preferred Stock, Shares Issued upon Conversion 8.89 shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2013-12-31 | 8.89 shares 10-K · filed 2014-03-07 |
| 2012-06-30 | 1.15M shares 10-Q/A · filed 2012-09-07 |
| 2012-04-30 | 9.86M shares 10-Q · filed 2012-11-14 |
| 2011-12-29 | 8.89 shares 10-K · filed 2013-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |